Reduced‐dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B‐cell acute lymphoblastic leukemia

Reduced‐dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B‐cell acute lymphoblastic leukemia

Abstract Background Blinatumomab early‐line treatment in B‐cell precursor acute lymphoblastic leukemia (B‐ALL) might improve clinical outcomes. Methods We conducted a retrospective real‐world cohort analysis in 20 newly diagnosed B‐ALL patients who received reduced‐dose chemotherapy (idarubicin, vin...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Jing Lu, Huifen Zhou, Xin Zhou, Yonggong Yang, Laigen Tong, Miao Miao, Xiaofei Yang, Suning Chen
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Wiley 2024-03-01
Ráidu:Cancer Medicine
Fáttát:
B‐cell acute lymphoblastic leukemia
blinatumomab
induction therapy
reduced‐dose chemotherapy
Liŋkkat:https://doi.org/10.1002/cam4.7062

Interneahtta

https://doi.org/10.1002/cam4.7062

Geahča maid